You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00160394 ↗ Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris Completed GlaxoSmithKline Phase 4 2004-12-01 Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity.
NCT00160394 ↗ Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris Completed Stiefel, a GSK Company Phase 4 2004-12-01 Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity.
NCT00807014 ↗ Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne Completed GlaxoSmithKline Phase 4 2006-11-01 The objectives of this clinical trial are to compare the quality of life of the subjects, the efficacy and the tolerance of Duac® Gel (gel formulation with a combination of clindamycin phosphate [equivalent to 1% clindamycin] and 5% benzoyl peroxide), applied once daily, against Differin® Gel (gel with 0.1% adapalene), used once daily, in the treatment of mild to moderate acne vulgaris.
NCT00807014 ↗ Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne Completed Stiefel, a GSK Company Phase 4 2006-11-01 The objectives of this clinical trial are to compare the quality of life of the subjects, the efficacy and the tolerance of Duac® Gel (gel formulation with a combination of clindamycin phosphate [equivalent to 1% clindamycin] and 5% benzoyl peroxide), applied once daily, against Differin® Gel (gel with 0.1% adapalene), used once daily, in the treatment of mild to moderate acne vulgaris.
NCT01015638 ↗ Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications Completed GlaxoSmithKline Phase 4 2009-08-01 This is a single-blind (blinded expert grader) study that will enroll 25-30 healthy volunteers without facial acne. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide 5% or clindamycin phosphate and benzoyl peroxide 2.5% and the other side of the face will remain non-treated to serve as a control.
NCT01015638 ↗ Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications Completed Stiefel, a GSK Company Phase 4 2009-08-01 This is a single-blind (blinded expert grader) study that will enroll 25-30 healthy volunteers without facial acne. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide 5% or clindamycin phosphate and benzoyl peroxide 2.5% and the other side of the face will remain non-treated to serve as a control.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Condition Name

Condition Name for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Intervention Trials
Acne Vulgaris 10
Acne 1
Actinic Keratosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Intervention Trials
Acne Vulgaris 11
Keratosis, Actinic 1
Keratosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Trials by Country

Trials by Country for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Location Trials
United States 13
India 10
China 9
Poland 1
Spain 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Location Trials
New York 3
Pennsylvania 2
Texas 1
New Mexico 1
Nebraska 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Clinical Trial Phase

Clinical Trial Phase for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Clinical Trial Phase Trials
Phase 4 5
Phase 3 4
Phase 2 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Clinical Trial Phase Trials
Completed 10
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Sponsor Name

Sponsor Name for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Sponsor Trials
GlaxoSmithKline 5
Stiefel, a GSK Company 4
Zeichner, Joshua, M.D. 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Sponsor Trials
Industry 16
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.